A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiske detaljer
Hovedforfatter:	Islam, Saidul
Andre forfattere:	Sharmin, Shahana
Format:	Thesis
Sprog:	English
Udgivet:	Brac University 2022
Fag:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Online adgang:	http://hdl.handle.net/10361/17308

Lignende værker

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
af: Karim, Azrin
Udgivet: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
af: Flora, Sanzida Alam
Udgivet: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
af: Meem, Manila
Udgivet: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
af: Alam, Tahera
Udgivet: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
af: Jahan, Nusrat
Udgivet: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
af: Ahmed, Nafisa
Udgivet: (2023)

Immunotherapy in the Management of Lung Cancer
af: Tasnim, Humayra
Udgivet: (2022)

A review on triple-negative breast cancer and its potential treatment
af: Niasa, Jannatul Ferdous
Udgivet: (2023)

Stem cells as therapeutic carrier in cancer treatment
af: Anika, Mysha Yeasmin
Udgivet: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
af: Hasan, Amit
Udgivet: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
af: Chakraborty, Anuradha
Udgivet: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
af: Khan, Muidul Hasan
Udgivet: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
af: Roy, Hredita
Udgivet: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
af: Emon, Kamrul Hasan
Udgivet: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
af: Mirza, Maisa Tasnim
Udgivet: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
af: Khan, Rezia Nowrin
Udgivet: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
af: Nuha, Nabiha Tahsin
Udgivet: (2024)

Role of statins as antagonists of SPARC in gastric cancer
af: Shahmat, Rad
Udgivet: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
af: Sorno, Rubina Haque
Udgivet: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
af: Ratu, Tabassum
Udgivet: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
af: Choki, Kinley
Udgivet: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
af: Razna, Amrin Islam
Udgivet: (2019)

A comprehensive review on drug repurposing in cancer treatment
af: Sarkar, Onusree
Udgivet: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
af: Mahaleka, Aarshi
Udgivet: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
af: Shaikat, Mahdi Mubin
Udgivet: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
af: Hasan, Sakib
Udgivet: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
af: Nawar, Anika
Udgivet: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
af: Deeba, Maliha Tasnim
Udgivet: (2018)

Targeting BRAFV600E in the treatment of CRC
af: Roja, Mashwiyat Samrin
Udgivet: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
af: Alam, Kazi Tasnuva
Udgivet: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
af: Rahman, Sanjida
Udgivet: (2024)

Biosimilar in lymphoma treatment
af: Tanisha, Mehrin Haque
Udgivet: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
af: Khondokar, Faiza
Udgivet: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
af: Islam, Nahidul
Udgivet: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
af: Beruni, Sajid Mahmud Al
Udgivet: (2022)

Oncogenes: new targets in cancer treatment
af: Chowdhury, Waseka Shams
Udgivet: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
af: Muntaha, Habibatul
Udgivet: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
af: Haque, Mushfiqul
Udgivet: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
af: Karim, Samia Binte
Udgivet: (2024)